EntryPoint Capital’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,219	Closed	-$176K	–	817
2024 Q3	$176K	Buy	+33,219	New	+$176K	0.1%	497
2024 Q2	–	Sell	-15,893	Closed	-$112K	–	1177
2024 Q1	$112K	Buy	+15,893	New	+$112K	0.1%	350